Last 12 months
Inside the activity.
1 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 12, 2026 23:34 UTC |
Beckerle Mary CDirector
|
SaleCommon Stock | 9,812 | $53.66 | $526,511.92 |
DisclosureSEC source: 0000939767-26-000101 · wk-form4_1786577638.xml · nonDerivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,079 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026. F2 · price: Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $53.16 to $54.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F3 · balance_after: Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 22:52 UTC |
WYSZOMIERSKI JACK LDirector
|
SaleCommon Stock | 3,925 | $50.55 | $198,408.75 |
DisclosureSEC source: 0000939767-26-000085 · wk-form4_1780527122.xml · nonDerivative · entry 1 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,384 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025. F2 · balance_after: Includes 8,367 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 22:51 UTC |
Eckhardt Sue GailDirector
|
SaleCommon Stock | 9,812 | $50.14 | $491,973.68 |
DisclosureSEC source: 0000939767-26-000084 · wk-form4_1780527116.xml · nonDerivative · entry 1 Eckhardt Sue Gail · CIK 0001823769 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,079 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025. F2 · price: Represents the weighted average sales price. The shares of Exelixis, Inc. common Stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.73 to $50.61. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F3 · balance_after: Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
PAPADOPOULOS STELIOSDirector
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000083 · wk-form4_1780091030.xml · nonDerivative · entry 1 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,197,595 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
Heyman Tomas J.Director
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000082 · wk-form4_1780091024.xml · nonDerivative · entry 1 Heyman Tomas J. · CIK 0001814673 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,649 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 17,455 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
Freire Maria CDirector
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000079 · wk-form4_1780091007.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,186 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
Eckhardt Sue GailDirector
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000081 · wk-form4_1780091018.xml · nonDerivative · entry 1 Eckhardt Sue Gail · CIK 0001823769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,891 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
Smith JulieDirector
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000080 · wk-form4_1780091013.xml · nonDerivative · entry 1 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,957 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
Beckerle Mary CDirector
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000078 · wk-form4_1780091001.xml · nonDerivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,891 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
Oliver BobDirector
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000077 · wk-form4_1780090995.xml · nonDerivative · entry 1 Oliver Bob · CIK 0001694534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,487 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 17,455 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
WYSZOMIERSKI JACK LDirector
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000076 · wk-form4_1780090989.xml · nonDerivative · entry 1 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,309 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC |
POSTE GEORGEDirector
|
GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000075 · wk-form4_1780090983.xml · nonDerivative · entry 1 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,199 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 27, 2026 Filed May 29, 2026 20:30 UTC |
JOHNSON DAVID EDWARDDirector
Caligan Partners LPDirector · See Remarks
|
GrantOption (right to buy) · Derivative | 19,133 | $0.00 Strike: $50.03 | $0.00 |
DisclosureSEC source: 0000902664-26-002641 · ownership.xml · derivative · entry 1 JOHNSON DAVID EDWARD · CIK 0001785557 · Director Caligan Partners LP · CIK 0001727492 · Director · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,133 Underlying: Common Stock · 19,133 shares Expires 2033-05-26 F1 · derivative.exercise_date: Option granted to David Johnson ("Mr. Johnson") pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to Mr. Johnson's continuous service through such date. F2 · ownership.direct: Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP (the "Caligan Master Fund") and managed accounts to which Caligan Partners LP ("Caligan") serves as investment manager (the "Caligan Accounts", together with the Caligan Master Fund, the "Caligan Master Fund and Accounts"), and may, after vesting, if applicable, transfer the securities directly to the Caligan Master Fund and Accounts. Read SEC document |
| May 26, 2026 Filed May 28, 2026 22:25 UTC |
Aftab DanaEVP, Research and Development
|
SaleCommon Stock | 43,451 | $50.35 | $2,187,757.85 |
DisclosureSEC source: 0000939767-26-000070 · wk-form4_1780007115.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 594,741 F1 · balance_after: Includes 405,966 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 20, 2026 Filed May 22, 2026 21:01 UTC |
Haley Patrick J.EVP, Commercial
|
SaleCommon Stock | 32,110 | $49.81 | $1,599,399.10 |
DisclosureSEC source: 0000939767-26-000069 · wk-form4_1779483702.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,638 F1 · price: Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 18, 2026 Filed May 19, 2026 22:58 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 124,047 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000068 · wk-form4_1779231526.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,004,327 F3 · shares: On May 18, 2026, the Reporting Person gifted 124,047 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F4 · balance_after: Shares of Common Stock held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| May 18, 2026 Filed May 19, 2026 22:58 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 124,047 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000068 · wk-form4_1779231526.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,362,008 F3 · shares: On May 18, 2026, the Reporting Person gifted 124,047 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 1,362,008 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 18, 2026 Filed May 19, 2026 22:58 UTC |
Senner Christopher J.EVP and CFO
|
SaleCommon Stock | 34,901 | $50.00 | $1,745,050.00 |
DisclosureSEC source: 0000939767-26-000067 · wk-form4_1779231521.xml · nonDerivative · entry 2 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 952,317 F3 · price: Represents the weighted average sales price. The shares of Common Stock were sold in multiple transactions at prices ranging from $50.00 to $50.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. F2 · balance_after: Includes 403,915 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 18, 2026 Filed May 19, 2026 22:58 UTC |
Hefti BrendaSVP and General Counsel
|
SaleCommon Stock | 6,625 | $50.21 | $332,641.25 |
DisclosureSEC source: 0000939767-26-000065 · wk-form4_1779231509.xml · nonDerivative · entry 2 Hefti Brenda · CIK 0002097579 · SVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,762 F3 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025. F4 · price: Represents the weighted average sales price. The shares of Common Stock were sold in multiple transactions at prices ranging from $49.84 to $50.51. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. F2 · balance_after: Includes 106,039 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs, the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs") and 167 shares of Common Stock acquired on April 30, 2026, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:58 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Tax withholdingCommon Stock | 128,497 | $51.10 | $6,566,196.70 |
DisclosureSEC source: 0000939767-26-000068 · wk-form4_1779231526.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,486,055 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025. F2 · balance_after: Includes 1,362,008 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:58 UTC |
Senner Christopher J.EVP and CFO
|
Tax withholdingCommon Stock | 40,892 | $51.10 | $2,089,581.20 |
DisclosureSEC source: 0000939767-26-000067 · wk-form4_1779231521.xml · nonDerivative · entry 1 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 987,218 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025. F2 · balance_after: Includes 403,915 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:58 UTC |
Haley Patrick J.EVP, Commercial
|
Tax withholdingCommon Stock | 33,265 | $51.10 | $1,699,841.50 |
DisclosureSEC source: 0000939767-26-000066 · wk-form4_1779231515.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,748 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025. F2 · balance_after: Includes 356,992 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs, the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs") and 646 shares of Common Stock acquired on April 30, 2026, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:58 UTC |
Hefti BrendaSVP and General Counsel
|
Tax withholdingCommon Stock | 6,411 | $51.10 | $327,602.10 |
DisclosureSEC source: 0000939767-26-000065 · wk-form4_1779231509.xml · nonDerivative · entry 1 Hefti Brenda · CIK 0002097579 · SVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,387 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, February 29, 2024, and February 26, 2025. F2 · balance_after: Includes 106,039 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs, the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs") and 167 shares of Common Stock acquired on April 30, 2026, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:58 UTC |
Aftab DanaEVP, Research and Development
|
Tax withholdingCommon Stock | 30,578 | $51.10 | $1,562,535.80 |
DisclosureSEC source: 0000939767-26-000064 · wk-form4_1779231503.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638,192 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025. F2 · balance_after: Includes 405,966 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs, the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs") and 646 shares of Common Stock acquired on April 30, 2026, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC |
Beckerle Mary CDirector
|
Exercise / conversionOption (right to buy) · Derivative | 3,856 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0000939767-26-000063 · wk-form4_1778281427.xml · derivative · entry 3 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,854 Underlying: Common Stock · 3,856 shares Expires 2031-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC |
Beckerle Mary CDirector
|
SaleCommon Stock | 7,712 | $48.45 | $373,646.40 |
DisclosureSEC source: 0000939767-26-000063 · wk-form4_1778281427.xml · nonDerivative · entry 2 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,524 F1 · balance_after: Includes 17,524 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC |
Beckerle Mary CDirector
|
Exercise / conversionCommon Stock | 3,856 | $23.24 | $89,613.44 |
DisclosureSEC source: 0000939767-26-000063 · wk-form4_1778281427.xml · nonDerivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 17,524 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC |
Freire Maria CDirector
|
Exercise / conversionOption (right to buy) · Derivative | 20,634 | $0.00 Strike: $19.77 | $0.00 |
DisclosureSEC source: 0000939767-26-000062 · wk-form4_1778281421.xml · derivative · entry 3 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,634 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC |
Freire Maria CDirector
|
SaleCommon Stock | 20,634 | $46.00 | $949,164.00 |
DisclosureSEC source: 0000939767-26-000062 · wk-form4_1778281421.xml · nonDerivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,819 F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC |
Freire Maria CDirector
|
Exercise / conversionCommon Stock | 20,634 | $19.77 | $407,934.18 |
DisclosureSEC source: 0000939767-26-000062 · wk-form4_1778281421.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC |
POSTE GEORGEDirector
|
SaleCommon Stock | 60,000 | $45.71 | $2,742,600.00 |
DisclosureSEC source: 0000939767-26-000061 · wk-form4_1778281415.xml · nonDerivative · entry 1 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,832 F1 · price: Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $45.65 to $45.85. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 9,812 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| May 06, 2026 Filed May 8, 2026 23:03 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 109,676 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000060 · wk-form4_1778281409.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,880,280 F1 · kind: On May 6, 2026, the Reporting Person gifted 109,676 shares of Exelixis, Inc. common stock ("Common Stock") to the Bombora Rise Foundation. F2 · balance_after: Shares of Common Stock held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 00:59 UTC |
Aftab DanaEVP, Research and Development
|
GrantCommon Stock | 52,018 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000037 · wk-form4_1772499575.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668,124 F1 · date: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F1 · shares: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F2 · balance_after: Includes 466,061 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 00:59 UTC |
Hefti BrendaSVP and General Counsel
|
GrantCommon Stock | 23,119 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000035 · wk-form4_1772499563.xml · nonDerivative · entry 1 Hefti Brenda · CIK 0002097579 · SVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,631 F1 · date: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F1 · shares: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F2 · balance_after: Includes 119,075 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 00:59 UTC |
Senner Christopher J.EVP and CFO
|
GrantCommon Stock | 52,018 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000036 · wk-form4_1772499569.xml · nonDerivative · entry 1 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,028,110 F1 · date: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F1 · shares: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F2 · balance_after: Includes 479,708 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 00:59 UTC |
Haley Patrick J.EVP, Commercial
|
GrantCommon Stock | 40,459 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000034 · wk-form4_1772499558.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,367 F1 · date: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F1 · shares: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F2 · balance_after: Includes 422,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 00:59 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GrantCommon Stock | 160,437 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000033 · wk-form4_1772499552.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,614,552 F3 · date: Represents shares of Common Stock that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F3 · shares: Represents shares of Common Stock that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. F4 · balance_after: Includes 1,614,552 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 23:41 UTC |
Aftab DanaEVP, Research and Development
|
SaleCommon Stock | 47,918 | $44.50 | $2,132,351.00 |
DisclosureSEC source: 0000939767-26-000032 · wk-form4_1772149294.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 616,106 F1 · balance_after: Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 24, 2026 Filed Mar 3, 2026 00:59 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 100,278 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000033 · wk-form4_1772499552.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,989,956 F1 · kind: On February 24, 2026, the Reporting Person gifted 100,278 shares of Exelixis, Inc. common stock ("Common Stock") to the Bombora Rise Foundation. F2 · balance_after: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 23:50 UTC |
Aftab DanaEVP, Research and Development
|
SaleCommon Stock | 29,873 | $44.35 | $1,324,867.55 |
DisclosureSEC source: 0000939767-26-000031 · wk-form4_1771890600.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 664,024 F1 · balance_after: Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 01:49 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 125,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 7 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,090,234 F6 · kind: On February 18, 2026, the Reporting Person gifted 125,094 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F5 · balance_after: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 01:49 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 125,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,454,115 F6 · kind: On February 18, 2026, the Reporting Person gifted 125,094 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 01:48 UTC |
Hefti BrendaSVP and General Counsel
|
SaleCommon Stock | 18,669 | $44.01 | $821,622.69 |
DisclosureSEC source: 0000939767-26-000022 · wk-form4_1771465726.xml · nonDerivative · entry 2 Hefti Brenda · CIK 0002097579 · SVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,512 F3 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025. F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. F2 · balance_after: Includes 95,956 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
Exercise / conversionOption (right to buy) · Derivative | 20,030 | $0.00 Strike: $21.69 | $0.00 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · derivative · entry 9 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,030 shares Expires 2031-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 20,030 shares of Common Stock, became fully exercisable on May 31, 2024. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
Exercise / conversionOption (right to buy) · Derivative | 44,087 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · derivative · entry 8 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,087 shares Expires 2030-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 44,087 shares of Common Stock, became fully exercisable on June 1, 2023. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
SaleCommon Stock | 20,030 | $44.30 | $887,329.00 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · nonDerivative · entry 6 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,590 F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
Exercise / conversionCommon Stock | 20,030 | $21.69 | $434,450.70 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · nonDerivative · entry 5 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
SaleCommon Stock | 44,087 | $44.50 | $1,961,871.50 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · nonDerivative · entry 4 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,590 F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
Exercise / conversionCommon Stock | 44,087 | $19.39 | $854,846.93 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · nonDerivative · entry 3 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 18, 2026 Filed Feb 21, 2026 01:36 UTC |
WYSZOMIERSKI JACK LDirector
|
Exercise / conversionOption (right to buy) · Derivative | 20,634 | $0.00 Strike: $19.77 | $0.00 |
DisclosureSEC source: 0000939767-26-000030 · wk-form4_1771637788.xml · derivative · entry 3 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,634 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.